Table 2.
Per 5% Increase in rSO2 | rSO2 < 30% vs rSO2 ≥ 30% | |||
---|---|---|---|---|
Outcome | Odds Ratio (95% CI) |
P Value | Odds Ratio (95% CI) |
P Value |
Death within 14 d | 0.72 (0.56 to 0.93) | .01 | 3.13 (1.20 to 8.11) | .02 |
Death within 14 d, adjustedb | 0.48 (0.29 to 0.77) | .003 | 5.79 (1.54 to 21.80) | .009 |
Death within 30 d | 0.73 (0.58 to 0.91) | .005 | 3.42 (1.46 to 8.00) | .005 |
Death within 30 d, adjustedb | 0.65 (0.45 to 0.93) | .02 | 3.96 (1.19 to 13.15) | .02 |
Clinical parametersc | ||||
CSF opening pressure > 250 mm H2O | 0.88 (0.69 to 1.11) | .28 | 1.26 (0.41 to 3.87) | .68 |
Pulse oximetry < 94% sa02 | 0.93 (0.66 to 1.33) | .70 | 1.47 (0.33 to 6.57) | .61 |
Mean arterial pressure < 84 mmhg | 0.86 (0.66 to 1.12) | .25 | 1.53 (0.51 to 4.60) | .45 |
Glasgow Coma Scale < 15 | 0.98 (0.83 to 1.16) | .80 | 0.84 (0.38 to 1.85) | .67 |
Abbreviations: CI, confidence interval; CSF, cerebrospinal fluid; rSO2 = regional cerebral tissue oxygenation.
aUnadjusted logistic regression models using the first rSO2 measurement in days 1–14.
bModels adjusted for Glasgow Coma Scale <15, CSF white cells >5 cells/μL, CSF quantitative culture, temperature, and anemia (<11 g/dL for men, <10.5 g/dL for women).
cClinical outcomes on or after the rSO2 measurement.